Blue Bird Is Positioned For Continued Growth, Looks Even More Attractive Now
Blue Bird Corporation reported strong FY24 results with double-digit top-line growth. Click here to find out what makes BLBD ...
Eli Lilly’s Zepbound outperforms Novo's Wegovy for weight loss in head-to-head trial
Eli Lilly's weight-loss drug Zepbound outperformed Novo Nordisk's Wegovy in a head-to-head trial, leading to a rise ...